Valuation: Illumina, Inc.

Market Cap 32.2B 27.58B 25.81B 23.62B 44.34B 3,081B 44.92B 305B 119B 1,548B 121B 118B 5,119B P/E 2026 *
43.1x
P/E 2027 * 36.4x
Enterprise Value 32.45B 27.79B 26B 23.8B 44.67B 3,104B 45.26B 307B 120B 1,559B 122B 119B 5,158B EV / Sales 2026 *
7.02x
EV / Sales 2027 * 6.41x
Free-Float
74.97%
Yield 2026 *
-
Yield 2027 * -
1 day+2.89%
1 week+14.94%
Current month+6.97%
1 month+13.96%
3 months+51.49%
6 months+82.01%
Current year+67.28%
1 week 187.54
Extreme 187.541
220.43
1 month 186.64
Extreme 186.64
220.43
Current year 112.65
Extreme 112.65
220.43
1 year 88
Extreme 88
220.43
3 years 68.7
Extreme 68.7
220.43
5 years 68.7
Extreme 68.7
492.29
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer 55 29/05/2025
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap.
05/08/26
Corvex Management LP
SellCompany -283,269 0.1872%
05/08/26 Free

Executive/Senior Manager

15,011 0.0099%
04/08/26 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+2.89%+14.94%+120.97%+31.06% 32.2B
+0.27%+5.60%+27.17%+18.20% 232B
+1.36%+7.34%+3.52%-12.95% 152B
+1.16%-3.98%-19.38%+32.14% 132B
+2.03%-2.55%-52.50%+0.36% 71.55B
-0.04%-2.99%+10.32%+17.25% 51.78B
+0.98%+2.97%-16.53%-11.67% 51.75B
+1.73%+6.50%+33.49%+33.33% 44.14B
+1.49%-0.68%+38.41%+52.11% 39.76B
+1.03%+1.53%+2.28%+8.48% 33.45B
Average +1.36%+1.48%+14.78%+16.83% 84.07B
Weighted average by Cap. +0.83%+1.74%+8.53%+13.86%

Financials

2026 *2027 *
Net sales 4.62B 3.96B 3.71B 3.39B 6.37B 442B 6.45B 43.79B 17.08B 222B 17.37B 16.99B 735B 4.91B 4.21B 3.94B 3.6B 6.76B 470B 6.85B 46.5B 18.13B 236B 18.44B 18.04B 781B
Net income 760M 651M 609M 558M 1.05B 72.75B 1.06B 7.2B 2.81B 36.55B 2.85B 2.79B 121B 891M 763M 714M 654M 1.23B 85.27B 1.24B 8.44B 3.29B 42.84B 3.35B 3.27B 142B
Net Debt 246M 211M 197M 181M 339M 23.54B 343M 2.33B 909M 11.82B 924M 904M 39.11B -729M -624M -584M -535M -1B -69.75B -1.02B -6.9B -2.69B -35.04B -2.74B -2.68B -116B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
22/08/26 $219.40 +2.89% 1,916,877
20/08/26 $213.24 +4.02% 3,284,715
19/08/26 $205.00 +8.87% 2,090,865
18/08/26 $188.29 -2.51% 1,192,959
17/08/26 $193.14 +1.18% 995,956
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
213.24USD
Average target price
198.89USD
Spread / Average Target
-6.73%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock